Newborn · Severe Jaundice
Exchange Transfusion for Severe Newborn Jaundice
When phototherapy isn't enough for newborn jaundice — exchange transfusion replaces baby's blood with donor blood to prevent kernicterus. Rare in modern UK (~1 in 10,000). NICE CG98 / AAP 2022.
Last reviewed 2 June 2026
AAP 2022 exchange-transfusion threshold
When is exchange transfusion indicated?
Exchange transfusion in practice
- Double-volume exchange (~ 160 mL/kg) using fresh whole blood or reconstituted from PRBC + FFP, ABO/Rh-compatible, irradiated, CMV-safe.
- Removes ~ 85 % of circulating bilirubin and antibodies in isoimmune disease.
- Complications: hypocalcaemia, thrombocytopenia, hypoglycaemia, acid-base disturbance, vascular complications, NEC, infection.
- Albumin 1 g/kg over 2 h pre-exchange in cases with albumin < 3.0 g/dL improves bilirubin-binding capacity.
- Acute bilirubin encephalopathy (ABE / kernicterus) features → immediate exchange regardless of level.
Educational tool only — not medical advice. AAP 2022 hyperbilirubinemia CPG (Kemper Pediatrics 2022). Race was REMOVED as a risk factor (vs 2004 CPG). Companion newborn-bilirubin covers phototherapy thresholds. Always cross-reference against the official AAP 2022 nomograms or BiliTool app for clinical use.
What does this mean?
Exchange transfusion is the rescue intervention when intensive phototherapy fails to control severe hyperbilirubinaemia — it physically removes circulating bilirubin and (in isoimmune disease) maternal antibodies. The AAP 2022 thresholds are LOWER than 2004 for at-risk infants but HIGHER for many term babies without neurotoxicity risk factors — the goal is keeping bilirubin safely below the neurotoxic range while NOT over-treating. Critical concept: the curves are NOT just “higher than phototherapy” — they encode a dynamic risk model based on gestational age, postnatal hour, and individual risk factors (isoimmune haemolysis, G6PD deficiency, sepsis, low albumin, acidosis). Escalation-of-care threshold (exchange − 2 mg/dL) is the pre-exchange action point: NICU-level intensive phototherapy, IV hydration, q2–3h TSB, albumin priming if low. The 2022 CPG’s biggest change was REMOVING race as a risk factor (no biological basis) — some pre-2022 calculators still use the old categories. Kernicterus remains a preventable cause of permanent neurodisability and the entire AAP 2022 framework exists to eliminate it.
What is exchange transfusion?
Emergency treatment for very high newborn bilirubin. Baby’s blood gradually replaced with donor blood via umbilical catheters. Removes bilirubin + antibody-coated red cells.
Prevents kernicterus (permanent brain damage). NICU procedure; 2-4 hours. Rare in modern UK — ~1 in 10,000 births.
When indicated
- Bilirubin above NICE exchange line.
- Rapid rise despite intensive phototherapy.
- Bilirubin / albumin ratio very high.
- Acute bilirubin encephalopathy signs (lethargy, abnormal tone, high-pitched cry, seizures) — emergency.
Common causes: Rh disease, ABO incompatibility, severe G6PD, sepsis.
How it’s done
- NICU on warmer.
- Umbilical catheters placed (artery + vein).
- Small aliquots withdrawn + donor blood given alternately.
- Repeated until ~2x blood volume exchanged (~85-170 mL/kg).
- Continuous monitoring (HR, BP, oxygen, glucose, electrolytes).
- 2-4 hours total.
Risks
- Death (~0.3-3% modern).
- Infection.
- Electrolyte imbalance.
- Air embolism.
- Bleeding (citrate anticoagulant).
- Thrombosis (catheter).
- Necrotising enterocolitis.
- Rare intracranial haemorrhage.
Risk-benefit favours exchange at indicated levels — preventing permanent kernicterus.
Without exchange — risk
Kernicterus — permanent brain injury:
- Athetoid cerebral palsy.
- Sensorineural deafness.
- Learning disability.
- Movement disorders.
- Dental enamel dysplasia.
Preventable with timely intervention.
IVIG alternative
Intravenous immunoglobulin can reduce need for exchange in antibody-mediated haemolysis (Rh, ABO). Blocks antibody-receptor reaction. Safer than exchange; sometimes used alongside in severe disease.
Donor blood
- Typed to baby + cross-matched to mother’s serum.
- Usually O-negative.
- New (<7 days), CMV-negative, irradiated.
- NHS Blood + Transplant rigorous safety.
Breastfeeding
NPO during procedure + ~6h pre. Post-exchange: gradual return. Express milk in interim — hospital pump. Resumed within 24-48h typically.
NICU stay + follow-up
- NICU 2-7 days typical post-exchange.
- Continued phototherapy 24-48h.
- Bilirubin monitoring; second exchange rarely.
- Hearing screen (BERA).
- Developmental follow-up through 2 years.
- Anti-D / Rh management for next pregnancy.
Different scenarios
Scenario 1: Rh disease, bilirubin above exchange line at 24h
Exchange transfusion. IVIG often given alongside. Future pregnancies need fetal medicine specialist care.
Scenario 2: G6PD baby, bilirubin rising rapidly despite phototherapy
Exchange consideration. Identify + avoid triggers in future. Family screening.
Scenario 3: Premature 32-week baby, severe jaundice
Lower exchange threshold for preterm. Multiple lights + biliblanket + IVIG often tried first.
Scenario 4: Post-exchange, bilirubin stable, baby discharged day 5
Outpatient bilirubin checks. Hearing test at 4-6 weeks. Developmental review at health visitor visits.
Scenario 5: Future pregnancy after Rh disease baby
Specialist clinic. MCA Doppler monitoring for fetal anaemia. Intrauterine transfusion if severe.
Care guidance — exchange transfusion
- Reserved for very high bilirubin not responding to phototherapy.
- IVIG often tried first in antibody-mediated haemolysis.
- NICU procedure.
- Continued phototherapy + monitoring post.
- Hearing + developmental follow-up.
- Investigate + manage underlying cause.
- Anti-D prophylaxis for next pregnancy if Rh.
- Most children develop normally after timely treatment.
Sources
- NICE CG98. Jaundice in newborn babies under 28 days.
- AAP Clinical Practice Guideline (2022). Hyperbilirubinemia.
- BAPM. Exchange transfusion guidelines.
Recommended for this calculator
Frequently asked questions
What is exchange transfusion?
EMERGENCY treatment for VERY HIGH newborn bilirubin (severe jaundice). Baby's blood gradually replaced with donor blood — usually 2x baby's blood volume exchanged through umbilical catheters. REMOVES bilirubin + antibody-coated red cells; replaces with healthy red blood cells. PREVENTS KERNICTERUS (permanent brain damage from bilirubin crossing into the brain). PERFORMED in NICU; takes 2-4 hours. RARE in modern UK (~1 in 10,000 births) — phototherapy effective in most cases; exchange reserved for highest bilirubin levels not responding to intensive phototherapy.
When is exchange transfusion needed?
BILIRUBIN above NICE 'exchange line' on age-specific nomogram OR: (1) Rapid rise despite intensive phototherapy; (2) Bilirubin / albumin ratio very high; (3) ACUTE BILIRUBIN ENCEPHALOPATHY signs (lethargy, abnormal tone, high-pitched cry, seizures) — emergency. RH DISEASE / ABO INCOMPATIBILITY: more common reason today since wide phototherapy. ALSO used for severe G6PD haemolysis; sepsis-related; rare metabolic conditions. SHARED DECISION but often urgent.
How is the procedure done?
(1) BABY in NICU on warmer; (2) UMBILICAL CATHETERS placed (one in artery, one in vein); (3) SMALL ALIQUOTS of blood withdrawn (typically 5-20 mL based on weight) + donor blood given alternately; (4) PROCESS REPEATED until ~2x blood volume exchanged (~85-170 mL/kg over 2-4 hours); (5) MONITORING: HR, BP, oxygen, glucose, electrolytes, temperature; (6) SEDATION sometimes given. CALCIUM gluconate may be needed (citrate anticoagulant in donor blood). POST-PROCEDURE: continued phototherapy + monitoring.
What are the risks?
SIGNIFICANT — but justified when needed. RISKS: (1) DEATH (~0.3-3% in modern series); (2) INFECTION (sepsis); (3) ELECTROLYTE imbalance (hypocalcaemia, hyperkalaemia, hypoglycaemia); (4) AIR embolism; (5) BLEEDING (anticoagulant in donor blood); (6) THROMBOSIS (catheter related); (7) NECROTISING ENTEROCOLITIS; (8) INTRACRANIAL HAEMORRHAGE rare. BENEFITS: prevent KERNICTERUS — permanent brain damage which is irreversible. RISK-BENEFIT favours exchange at high bilirubin levels.
What happens if we don't do exchange transfusion?
RISK OF KERNICTERUS. CHRONIC bilirubin encephalopathy (brain injury): (1) ATHETOID CEREBRAL PALSY; (2) DEAFNESS (sensorineural); (3) LEARNING DISABILITY; (4) MOVEMENT disorders; (5) DENTAL enamel dysplasia. PERMANENT. PREVENTABLE with timely intervention. SOME parents understandably anxious — but exchange transfusion at indicated levels has been life-changing for severe jaundice over decades.
What donor blood is used?
BLOOD TYPED to baby's blood type + cross-matched to mother's serum (eliminates antibodies). USUALLY: O-NEGATIVE blood, NEW (typically <7 days old), CMV-negative, IRRADIATED (kills lymphocytes — prevents graft-vs-host disease), HIV/HEPATITIS screened. PACKED RED CELLS RECONSTITUTED with FFP (fresh frozen plasma) to make 'whole blood' substitute. NHS Blood + Transplant rigorous safety processes. SAFE — comparable risk profile to adult transfusion.
Does this prevent future jaundice?
ONE EXCHANGE addresses ACUTE jaundice. ONGOING haemolysis (red cell breakdown from underlying cause — Rh disease, ABO incompatibility, G6PD) continues. SOMETIMES NEED REPEAT exchange if bilirubin rises again. ALSO: continued PHOTOTHERAPY post-exchange usually 24-48 hours; bilirubin monitoring continues; sometimes need second exchange. INVESTIGATE UNDERLYING cause — Coombs test, G6PD, blood group, smear. ADDRESS cause through pregnancy + delivery for next baby.
Can my baby still breastfeed?
USUALLY YES after stabilising. DURING exchange: baby NPO (nothing by mouth) for ~6 hours pre + during. POST-EXCHANGE: gradual return to feeding; START with small amounts, progressing to full feeds. BREAST MILK / FORMULA: both acceptable. EXPRESS BREAST MILK in interim — hospital pump; partner / family can deliver to baby. EARLY skin-to-skin when stable. BREASTFEEDING typically resumed within 24-48 hours.
Will my baby need to stay in NICU long?
DEPENDS on cause + recovery. POST-EXCHANGE: 2-7 days NICU typically. MONITORING: bilirubin checks; investigation of cause; ensure no rebound severe enough for second exchange; observe for complications. DISCHARGE when: bilirubin stable below treatment line; eating well; gaining weight; underlying cause being managed; parents confident in care. FOLLOW-UP arranged (hearing screen, neurodevelopmental check).
What follow-up will baby need?
(1) HEARING SCREEN: bilirubin can affect inner ear — formal audiology test (BERA); (2) DEVELOPMENTAL FOLLOW-UP at intervals through first 2 years; (3) BILIRUBIN re-checks first 1-2 weeks; (4) ANTI-D / RH MANAGEMENT for future pregnancies; (5) G6PD avoidance counselling if diagnosed; (6) GP / health visitor review. MOST CHILDREN who needed exchange transfusion in modern care develop normally with no long-term issues.
Could this have been prevented?
PARTIALLY. (1) ANTI-D prophylaxis for Rh-negative mothers prevents Rh disease in future pregnancies — preventive; (2) Early identification of jaundice with TcB / SBR; (3) Prompt phototherapy at lower thresholds prevents bilirubin rising to exchange levels; (4) Adequate feeding from birth (frequent breastfeeding); (5) High-risk babies (Asian ethnicity, G6PD risk, blood group incompatibility) screened earlier. SOMETIMES inevitable despite all measures — biological severity beyond control.
Is this the same as a regular blood transfusion?
NO. REGULAR transfusion: top-up of blood without removing yours. EXCHANGE: REMOVES baby's blood + REPLACES with donor blood. Much more invasive procedure with greater risks. EXCHANGE addresses HIGH BILIRUBIN levels + REMOVES antibodies; regular transfusion treats LOW BLOOD COUNT only. PROCEDURE different + indication different.
What's IVIG and how does it relate?
IVIG (INTRAVENOUS IMMUNOGLOBULIN) — alternative to / adjunct with exchange transfusion. USED for: ANTIBODY-MEDIATED haemolysis (Rh, ABO). BLOCKS the antibody-receptor reaction → reduces haemolysis → reduces bilirubin rise. EVIDENCE: REDUCES need for exchange transfusion in some studies; mixed evidence; AAP recommends consideration in haemolytic disease with bilirubin rising despite intensive phototherapy. SAFER than exchange (most cases). SOMETIMES BOTH used in severe disease.
What about my future pregnancies?
IDENTIFY + treat cause. RH disease: anti-D antibody management; intrauterine transfusion if severe in next pregnancy. ABO INCOMPATIBILITY: similar planning. G6PD DEFICIENCY: same risk next baby (X-linked); avoid trigger foods/drugs; prepare team. INVESTIGATIONS in mother: antibody screen + identification; counselling about implications. PROACTIVE FETAL MEDICINE care from booking.
How does this relate to other calculators on BumpBites?
Companion: /calculators/newborn-bilirubin for assessment; /calculators/phototherapy-rebound; /calculators/anti-d-dosing for Rh prevention; /calculators/blood-type; /calculators/kleihauer-betke; /calculators/breastfeeding-latch (feeding helps clear).